Current and Future Pharmacologic Complement Inhibitors

Sep 16, 2017 by in HEMATOLOGY Comments Off on Current and Future Pharmacologic Complement Inhibitors

The availability of anticomplement therapies has been a major achievement for medicine in the last decade. Indeed, eculizumab has changed the treatment paradigm of paroxysmal nocturnal hemoglobinuria and atypical hemolytic…

read more

Thrombotic Microangiopathy

Sep 16, 2017 by in HEMATOLOGY Comments Off on Thrombotic Microangiopathy

Thrombotic microangiopathies (TMA) such as atypical hemolytic uremic syndrome (aHUS) have evolved from rare, fulminant childhood afflictions to uncommon diseases with acute and chronic phases involving both children and adults….

read more

Shiga Toxin Associated Hemolytic Uremic Syndrome

Sep 16, 2017 by in HEMATOLOGY Comments Off on Shiga Toxin Associated Hemolytic Uremic Syndrome

Shiga toxin associated hemolytic uremic syndrome (Stx HUS), a thrombotic microangiopathy, is the most common cause of pediatric acute kidney injury but has no direct treatment. A better understanding of…

read more

Congenital CD59 Deficiency

Sep 16, 2017 by in HEMATOLOGY Comments Off on Congenital CD59 Deficiency

The severe clinical symptoms of inherited CD59 deficiency confirm the importance of CD59 as essential complement regulatory protein for protection of cells against complement attack, in particular protection of hematopoietic…

read more

Paroxysmal Nocturnal Hemoglobinuria

Sep 16, 2017 by in HEMATOLOGY Comments Off on Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal nocturnal hemoglobinuria is manifests with a chronic hemolytic anemia from uncontrolled complement activation, a propensity for thrombosis and marrow failure. The hemolysis is largely mediated by the alternative pathway…

read more

Paroxysmal Cold Hemoglobinuria

Sep 16, 2017 by in HEMATOLOGY Comments Off on Paroxysmal Cold Hemoglobinuria

Paroxysmal cold hemoglobinuria is a rare cause of autoimmune hemolytic anemia predominantly seen as an acute form in young children after viral illnesses and in a chronic form in some…

read more

Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia

Sep 16, 2017 by in HEMATOLOGY Comments Off on Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia

Cold antibody types account for about 25% of autoimmune hemolytic anemias. Primary chronic cold agglutinin disease (CAD) is characterized by a clonal lymphoproliferative disorder. Secondary cold agglutinin syndrome (CAS) complicates…

read more

Warm Autoimmune Hemolytic Anemia

Sep 16, 2017 by in HEMATOLOGY Comments Off on Warm Autoimmune Hemolytic Anemia

Warm autoimmune hemolytic anemia (AIHA) is defined as the destruction of circulating red blood cells (RBCs) in the setting of anti-RBC autoantibodies that optimally react at 37°C. The pathophysiology of…

read more

Hemolysis from ABO Incompatibility

Sep 16, 2017 by in HEMATOLOGY Comments Off on Hemolysis from ABO Incompatibility

ABO incompatibility of red blood cells leads to brisk complement-mediated lysis, particularly in the setting of red cell transfusion. The ABO blood group is the most clinically significant blood group…

read more

Complement

Sep 16, 2017 by in HEMATOLOGY Comments Off on Complement

The complement system is an essential component of the immune system. It is a highly integrative system and has a number of functions, including host defense, removal of injured cells…

read more
Get Clinical Tree app for offline access